Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Harell D
Department of Medicine, Beilinson Medical Center, Petah Tiqva, Israel.
Diabet Med. 1996 May;13(5):457-63. doi: 10.1002/(SICI)1096-9136(199605)13:5<457::AID-DIA83>3.0.CO;2-T.
The aim of the present study was to elucidate the effect of diabetes and metabolic control on the presentation, sources, pathogens and outcome of common infections. Of 515 patients admitted to three departments of internal medicine because of a suspected acute infection, 132 (26%) had diabetes mellitus. Osteomyelitis was diagnosed in 3% of the diabetic patients and in 1% of patients without diabetes, and infection of the extremities in 7% and 0%, respectively (p = 0.003). Klebsiella sp. caused 24% of urinary tract infections in diabetic patients, versus 13% in patients without diabetes (p = 0.1). The percentage of Staphylococcus aureus infections in diabetic patients was 10% versus 5% in non-diabetic patients (p = 0.06). The gross mortality rate in the diabetic patients was 10%, and in patients without diabetes, 12%. In patients without fatal underlying disorders, mortality in the diabetic patients was 10% (2% in patients with glycosylated haemoglobin (GHb) lower than median, and 17% in patients with GHb higher than median) and in the non-diabetic patients 4% (p = 0.04). Five factors were independently and significantly related to mortality in diabetic patients: acute respiratory distress (very large odds-ratio [OR]), coma (OR 3.8, 95% confidence interval [CI] 1.0-14.3), GHb above the median (OR 3.3, 95% CI 1.8-6.2), the interaction between GHb and absence of a severe underlying disorder (OR 12.0, 95% CI 2.9-50.7) and duration of diabetes (OR of 1.072 for 1-year increment, and 1.42 for a 5-year increment). Choice of empiric antibiotic treatment in diabetic patients with suspected bacterial infection should take into account the preponderance of Klebsiella sp. and Staphylococcus aureus infections. The present results favour an association between poor glycaemic control and a fatal outcome of infectious diseases in diabetic patients.
本研究的目的是阐明糖尿病及代谢控制对常见感染的表现、感染源、病原体及转归的影响。在因疑似急性感染而入住三个内科科室的515例患者中,132例(26%)患有糖尿病。糖尿病患者中3%被诊断为骨髓炎,无糖尿病患者中这一比例为1%;糖尿病患者中7%发生肢体感染,无糖尿病患者中这一比例为0%(p = 0.003)。克雷伯菌属导致糖尿病患者中24%的尿路感染,无糖尿病患者中这一比例为13%(p = 0.1)。糖尿病患者中金黄色葡萄球菌感染的比例为10%,非糖尿病患者中为5%(p = 0.06)。糖尿病患者的总死亡率为10%,无糖尿病患者为12%。在无致命基础疾病的患者中,糖尿病患者的死亡率为10%(糖化血红蛋白(GHb)低于中位数的患者为2%,GHb高于中位数的患者为17%),非糖尿病患者为4%(p = 0.04)。五个因素与糖尿病患者的死亡率独立且显著相关:急性呼吸窘迫(优势比[OR]非常大)、昏迷(OR 3.8,95%置信区间[CI] 1.0 - 14.3)、GHb高于中位数(OR 3.3,95% CI 1.8 - 6.2)、GHb与无严重基础疾病之间的相互作用(OR 12.0,95% CI 2.9 - 50.7)以及糖尿病病程(病程每增加1年,OR为1.072;每增加5年,OR为1.42)。对于疑似细菌感染的糖尿病患者,经验性抗生素治疗的选择应考虑克雷伯菌属和金黄色葡萄球菌感染占优势的情况。目前的结果支持血糖控制不佳与糖尿病患者感染性疾病的致命转归之间存在关联。